Description
Dosing Chart -- Semaglutide
| Weekly dosage amount | ||||||
|---|---|---|---|---|---|---|
| Vial Size (mg) | 0.25mg | 0.50mg | 1mg | 1.5mg | 2mg | 2.5mg |
| 2.5mg | 10.0 Weeks | 5.0 Weeks | 2.5 Weeks | 1.7 Weeks | 1.3 Weeks | 1.0 Weeks |
| 5mg | 20.0 Weeks | 10.0 Weeks | 5.0 Weeks | 3.3 Weeks | 2.5 Weeks | 2.1 Weeks |
| 10mg | 40.0 Weeks | 20.0 Weeks | 10.0 Weeks | 6.7 Weeks | 5.0 Weeks | 4.2 Weeks |
| 15mg | 60.0 Weeks | 30.0 Weeks | 15.0 Weeks | 10.0 Weeks | 7.5 Weeks | 6.3 Weeks |
| 20mg | 80.0 Weeks | 40.0 Weeks | 20.0 Weeks | 13.3 Weeks | 10 Weeks | 8.3 Weeks |
Semaglutide Therapy (Brand & Compounded Options)
Semaglutide is the active ingredient found in weight-management and diabetes medications, including Ozempic® and Wegovy®. Through our network of licensed medical providers, we offer comprehensive therapy plans that may include semaglutide—whether you choose a brand-name option or a compounded version prepared by a licensed pharmacy. This approach ensures patients receive personalized care tailored to their unique health and metabolic needs.
Key Features:
•Brand & Compounded Availability: Patients can access either brand-name semaglutide (Ozempic®, Wegovy®) or a compounded version, depending on clinical, insurance, and financial considerations.
•Expert Medical Oversight: Our providers assess each patient’s metabolic profile and conduct ongoing monitoring, allowing for adjustments that optimize treatment results.
•Patient-Focused Care: Through personalized consultations, our team works with you to determine whether brand-name or compounded semaglutide aligns best with your health goals.
Important Information & Disclaimer:
•Compounded Medications: Compounded drug products are not approved or evaluated for safety, efficacy, or quality by the FDA. However, our partner pharmacies are licensed by the Board of Pharmacy and comply with FDA regulations under 503A and 503B.
•Brand Medications: Brand-name semaglutide (Ozempic®, Wegovy®) has undergone FDA review for specific indications. For questions about FDA approval, please consult your healthcare provider.
•Medical Supervision: Always discuss your individual health situation with a qualified medical professional to determine if semaglutide therapy—brand-name or compounded—is appropriate for you.
•No Claims of Cure: This therapy is not intended to diagnose, treat, cure, or prevent any disease.
These statements have not been evaluated by the Food and Drug Administration. Please consult with your licensed medical provider for individualized medical advice.
If you’re ineligible to receive therapy or medications – you will be fully refunded!
Book a consultation to speak to a provider about treatment options
